The Russian Sputnik V vaccine could have been approved by the European Medicines Agency (EMA) if it were evaluated only on medical grounds. This was stated in an interview with Izvestia by Petr Bystron, a member of the Bundestag Committee on International Affairs from Alternative for Germany.
“The approval decision is made by the EMA. The agency does not allow the use of the Russian vaccine for political and economic reasons. It protects the market so that large Western pharmaceutical companies can sell their drugs without competition. In addition, it does not want to ensure the inflow of foreign currency into Russia, ”said the Bundestag deputy.
At the same time, Petr Bystron is sure that, from a medical point of view, the Russian vaccine could have been registered long ago.
“If the EMA evaluated vaccines purely from a medical point of view, Sputnik V would have been approved in the EU a long time ago,” the politician said.
Earlier, the head of the European branch of the World Health Organization (WHO), Hans Kluge, said that more than half of the European population will be infected with the Omicron strain of coronavirus in the next 6-8 weeks. According to him, 50 out of 53 countries in Europe and Central Asia have now reported cases of Omicron. Kluge added that this variant of COVID-19 is rapidly becoming dominant in Western Europe and is now spreading to the Balkans.
Read more in the exclusive Izvestia article:
“Purely from a medical point of view, Sputnik V would have been approved long ago”
Source: IZ
Jane Stock is a technology author, who has written for 24 Hours World. She writes about the latest in technology news and trends, and is always on the lookout for new and innovative ways to improve his audience’s experience.
